omniture
鸿运华宁(杭州)生物医药有限公司 Hongyun Huaining (Hangzhou) Biomedical Co. LTD

Latest News

The World's First ETa-specific Monoclonal Antibody: Gmax Biopharm's GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease

HANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Gmax Biopharm LLC. announced today that its applicat...

2022-11-14 22:55 2448

Gmax's GMA106, second generation obesity/T2DM/NASH mAb gives first in human dose

HANGZHOU, China, Nov. 11, 2021 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of...

2021-11-11 18:00 1035

GMAX Zhengzhou Manufacturing Site Breaks Ground

HANGZHOU, China, Dec. 15, 2020 /PRNewswire/ -- Gmax Biopharm today holds ground-breaking ceremony f...

2020-12-15 18:00 1115

GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial

HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of...

2020-10-26 18:00 1317